Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

Cited by (970)

Items 201–300 of 970

1. Interaction between pathogenic proteins in neurodegenerative disorders
   K. A. Jellinger · 2011 · Journal of Cellular and Molecular Medicine
2. Biophysical Insights into How Surfaces, Including Lipid Membranes, Modulate Protein Aggregation Related to Neurodegeneration
   Burke, Kathleen A., Yates, Elizabeth A., Legleiter, Justin · 2013 · Frontiers in Neurology
3. The prion model for progression and diversity of neurodegenerative diseases
   Barbara Elena Stopschinski, Marc I. Diamond · 2017 · The Lancet Neurology
4. Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges
   Seongju Lee, Sakulrat Mankhong, Ju‐Hee Kang · 2019 · International Journal of Molecular Sciences
5. The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
   Asad Jan, Nádia Pereira Gonçalves, Christian Bjerggaard Vægter, Poul Henning Jensen, Nelson Ferreira · 2021 · International Journal of Molecular Sciences
6. Experimental transmissibility of mutant SOD1 motor neuron disease
   Jacob I. Ayers, Susan Fromholt, Morgan Koch, Adam DeBosier, Ben McMahon, Guilian M. Xu, David Borchelt · 2014 · Acta Neuropathologica
7. Amyloid structure and assembly: Insights from scanning transmission electron microscopy
   Claire S. Goldsbury, Ulrich Baxa, Martha N. Simon, Alasdair C. Steven, Andreas H. Engel, Joseph S. Wall, Ueli Aebi, Shirley Ann Müller · 2010 · Journal of Structural Biology
8. Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats
   Rebecca F. Rosen, Jason J. Fritz, Jeromy M. Dooyema, Amarallys F. Cintron, Tsuyoshi Hamaguchi, James J. Lah, Harry LeVine, Mathias Jucker, Lary C. Walker · 2011 · Journal of Neurochemistry
9. Seed‐induced Aβ deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer's disease
   Stephanie Ziegler‐Waldkirch, Paolo d’Errico, Jonas‐Frederic Sauer, Daniel Erny, Shakuntala Savanthrapadian, Desirée Loreth, Natalie Katzmarski, Thomas Blank, Marlene Bartos, Marco Prinz et al. · 2017 · The EMBO Journal
10. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study
    Ignazio Calì, Mark L. Cohen, Stéphane Haı̈k, Piero Parchi, Giorgio Giaccone, Steven John Collins, Diane Kofskey, Han Wang, Catriona McLean, Jean‐Philippe Brandel et al. · 2018 · Acta Neuropathologica Communications
11. β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development
    Xue‐Mei Zhang, Yan Cai, Kun Xiong, Huaibin Cai, Xuegang Luo, Jiachun Feng, Richard W. Clough, Robert G. Struble, Peter R. Patrylo, Xiao‐Xin Yan · 2009 · European Journal of Neuroscience
12. Alzheimer disease
    Justin M. Nussbaum, Matthew E. Seward, George S. Bloom · 2013 · Prion
13. Inhibition of amyloid-β plaque formation by α-synuclein
    Teresa Bachhuber, Natalie Katzmarski, Joanna F McCarter, Desirée Loreth, Sabina Tahirović, Frits Kamp, Claudia Abou‐Ajram, Brigitte Nuscher, Alberto Serrano‐Pozo, Alexandra Müller et al. · 2015 · Nature Medicine
14. The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity
    Cristina Cecchi, Massimo Stefani · 2013 · Biophysical Chemistry
15. Successive Stages of Amyloid-β Self-Assembly Characterized by Solid-State Nuclear Magnetic Resonance with Dynamic Nuclear Polarization
    Alexey Potapov, Wai‐Ming Yau, Rodolfo Ghirlando, Kent R. Thurber, Robert Tycko · 2015 · Journal of the American Chemical Society
16. Enrichment of cholesterol in microdissected Alzheimer’s disease senile plaques as assessed by mass spectrometry
    Maı̈ Panchal, Jacqueline Loeper, Jack‐Christophe Cossec, Claire Perruchini, Adina Nicoleta Lazar, Denis Pompon, Charles J. Duyckaerts · 2009 · Journal of Lipid Research
17. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Julie Dunys, Audrey Valverde, Frédéric Checler · 2018 · Journal of Biological Chemistry
18. Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies
    Hillen, Heinz, Barghorn, Stefan, Striebinger, Andreas, Labkovsky, Boris, Müller, Reinhold, Nimmrich, Volker, Nolte, Marc W., Perez-Cruz, Claudia, van der Auwera, Ingrid, van Leuven, Fred et al. · 2010 · The Journal of Neuroscience
19. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
    Gianluigi Forloni, Vladimiro Artuso, Pietro La Vitola, Claudia Balducci · 2016 · Movement Disorders
20. Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment
    Anna Margherita Corradi, Alessio Zanardi, Caterina Giacomini, Franco Onofri, Flavia Valtorta, Michèle Zoli, Fabio Benfenati · 2008 · Journal of Cell Science
21. Evidence for Age-Dependent in Vivo Conformational Rearrangement within Aβ Amyloid Deposits
    Sofie Nyström, Katarzyna Maria Psonka-Antonczyk, Pål Gunnar Ellingsen, Leif B. G. Johansson, Nina Kristine Reitan, Susann Handrick, Stefan Prokop, Frank L. Heppner, Bettina M. Wegenast‐Braun, Mathias Jucker et al. · 2013 · ACS Chemical Biology
22. Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein
    Walker S. Jackson · 2014 · Disease Models & Mechanisms
23. Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer's disease
    Watts, Joel C., Giles, Kurt, Grillo, Sunny K., Lemus, Azucena, DeArmond, Stephen J., Prusiner, Stanley B. · 2011 · Proceedings of the National Academy of Sciences
24. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water
    Calvin C. Willhite, Gwendolyn L. Ball, Clifton J. McLellan · 2012 · Critical Reviews in Toxicology
25. Fibrillation of the Major Curli Subunit CsgA under a Wide Range of Conditions Implies a Robust Design of Aggregation
    Morten Simonsen Dueholm, Søren B. Nielsen, Kim L. Hein, Poul Nissen, Matthew R. Chapman, Gunna Christiansen, Per Halkjær Nielsen, Daniel E. Otzen · 2011 · Biochemistry
26. Cellular Regulation of Amyloid Formation in Aging and Disease
    Esther Stroo, Mandy Koopman, Ellen A. A. Nollen, Alejandro Mata‐Cabana · 2017 · Frontiers in Neuroscience
27. Mouse Models for Studying the Formation and Propagation of Prions
    Joel C. Watts, Stanley B. Prusiner · 2014 · Journal of Biological Chemistry
28. Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle
    Aurel Popa‐Wagner, Ana-Maria Buga, Bogdan Ovidiu Popescu, Dafin Fior Muresanu · 2013 · Journal of Neural Transmission
29. Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases
    Jessica Tittelmeier, Eliana Nachman, Carmen I. Nussbaum-Krammer · 2020 · Frontiers in Aging Neuroscience
30. Brain injury, neuroinflammation and Alzheimer's disease
    Joshua J. Breunig, Marie‐Victoire Guillot‐Sestier, Terrence Town · 2013 · Frontiers in Aging Neuroscience
31. Can Parkinson's disease pathology be propagated from one neuron to another?
    Christopher J.R. Dunning, Juan F. Reyes, Jennifer A. Steiner, Patrik Brundin · 2011 · Progress in Neurobiology
32. Prions and the Potential Transmissibility of Protein Misfolding Diseases
    Allison Kraus, Bradley R. Groveman, Byron W. Caughey · 2013 · Annual Review of Microbiology
33. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain
    Rik Ossenkoppele, Leonardo Iaccarino, Daniel R. Schonhaut, Jesse A. Brown, Renaud La Joie, James P. O’Neil, Mustafa Janabi, Suzanne L. Baker, Joel H. Kramer, Maria‐Luisa Gorno‐Tempini et al. · 2019 · NeuroImage Clinical
34. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage
    Tetsade Piermartiri, Cláudia Pinto Figueiredo, Daniel Rial, Filipe Silveira Duarte, Sarah C. Bezerra, Gianni Mancini, Andreza Fabro De Bem, Rui Daniel Prediger, Carla I. Tasca · 2010 · Experimental Neurology
35. Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
    Wagner, Jessica, Degenhardt, Karoline, Veit, Marleen, Louros, Nikolaos, Konstantoulea, Katerina, Skodras, Angelos, Wild, Katleen, Liu, Ping, Obermüller, Ulrike, Bansal, Vikas et al. · 2022 · Nature
36. Apolipoprotein E aggregation in microglia initiates Alzheimer’s disease pathology by seeding β-amyloidosis
    Kaji, Seiji, Berghoff, Stefan A., Spieth, Lena, Schlaphoff, Lennart, Sasmita, Andrew O., Vitale, Simona, Büschgens, Luca, Kedia, Shreeya, Zirngibl, Martin, Nazarenko, Taisiia et al. · 2024 · Immunity
37. Dissecting the potential molecular mechanisms underlying α-synuclein cell-to-cell transfer in Parkinson's disease
    Élodie Angot, Patrik Brundin · 2009 · Parkinsonism & Related Disorders
38. Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective
    François Le Guerroué, Richard J. Youle · 2020 · Cell Death and Differentiation
39. The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain
    Tsuyoshi Hamaguchi, Yvonne S. Eisele, Nicholas H. Varvel, Bruce T. Lamb, Lary C. Walker, Mathias Jucker · 2011 · Acta Neuropathologica
40. Immunotherapy for Alzheimer's disease
    Thomas Wısnıewskı, Fernando Goñi · 2014 · Biochemical Pharmacology
41. Emerging Structural Understanding of Amyloid Fibrils by Solid-State NMR
    Beat H. Meier, Roland Riek, Anja Böckmann · 2017 · Trends in Biochemical Sciences
42. Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition
    Lorena Saelices, Kevin Chung, Ji Hun Lee, Whitaker Cohn, Julian P. Whitelegge, Merrill D. Benson, David S Eisenberg · 2018 · Proceedings of the National Academy of Sciences
43. Interplay of histidine residues of the Alzheimer’s disease Aβ peptide governs its Zn-induced oligomerization
    Andrei Istrate, Sergey A. Kozin, Sergey S Zhokhov, Alexey B. Mantsyzov, Olga I. Kechko, Annalisa Pastore, Alexander А. Makarov, Vladimir I. Polshakov · 2016 · Scientific Reports
44. Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
    Ola Philipson, Anna Lord, Astrid Gumucio, Paul W. O'Callaghan, Lars Lannfelt, Lars N. G. Nilsson · 2010 · FEBS Journal
45. Mechanisms of amyloid plaque pathogenesis
    John C. Fiala · 2007 · Acta Neuropathologica
46. PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease
    Rebecca F. Rosen, Lary C. Walker, Harry LeVine · 2009 · Neurobiology of Aging
47. Peripherally Applied Synthetic Peptide isoAsp7-Aβ(1-42) Triggers Cerebral β-Amyloidosis
    Sergey A. Kozin, Ivan B. Cheglakov, Armen A. Ovsepyan, Georgii B. Telegin, Philipp O. Tsvetkov, А.В. Лисица, Alexander А. Makarov · 2013 · Neurotoxicity Research
48. The Pharmacological Properties and Therapeutic Use of Apomorphine
    Samo Ribarič · 2012 · Molecules
49. Structural Evolution of Iowa Mutant β-Amyloid Fibrils from Polymorphic to Homogeneous States under Repeated Seeded Growth
    Wei Qiang, Wai‐Ming Yau, Robert Tycko · 2011 · Journal of the American Chemical Society
50. Review: Prion‐like mechanisms of transactive response DNA binding protein of 43 kDa ( TDP ‐43) in amyotrophic lateral sclerosis ( ALS )
    Phillip Smethurst, Katie C. L. Sidle, John Hardy · 2014 · Neuropathology and Applied Neurobiology
51. Multiple Factors Contribute to the Peripheral Induction of Cerebral -Amyloidosis
    Yvonne S. Eisele, Sarah K. Fritschi, Tsuyoshi Hamaguchi, Ulrike Obermüller, Petra Füger, Angelos Skodras, C. Schafer, Jörg Odenthal, Mathias F Heikenwälder, Matthias Staufenbiel et al. · 2014 · Journal of Neuroscience
52. Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis
    David G. Garbuz, Olga G. Zatsepina, Michael B. Evgen’ev · 2021 · Molecular Biology
53. Structural Typing of Systemic Amyloidoses by Luminescent-Conjugated Polymer Spectroscopy
    K. Peter R. Nilsson, Kristian Ikenberg, Andreas Åslund, Sophia Fransson, Peter Konradsson, Christoph Röcken, Holger Moch, Adriano Aguzzi · 2009 · American Journal Of Pathology
54. Inflammasome-mediated innate immunity in Alzheimer’s disease
    Venegas, Carmen, Heneka, Michael T. · 2019 · The FASEB Journal
55. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
    Yanuar Alan Sulistio, Klaus Heese · 2015 · Molecular Neurobiology
56. Prions and Protein Assemblies that Convey Biological Information in Health and Disease
    David W. Sanders, Sarah K. Kaufman, Brandon B. Holmes, Marc I. Diamond · 2016 · Neuron
57. An Asymmetric Dimer as the Basic Subunit in Alzheimer’s Disease Amyloid β Fibrils
    Juan Miguel López del Amo, Matthias Schmidt, Uwe Fink, Muralidar Dasari, Marcus Fändrich, Bernd Reif · 2012 · Angewandte Chemie International Edition
58. Review: Creutzfeldt–Jakob disease: prion protein type, disease phenotype and agent strain
    Mark W. Head, James W. Ironside · 2012 · Neuropathology and Applied Neurobiology
59. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers
    Ugalde, Cathryn L., Finkelstein, David I., Lawson, Victoria A., Hill, Andrew F. · 2016 · Journal of Neurochemistry
60. Pneumonia-induced endothelial amyloids reduce dendritic spine density in brain neurons
    Allison M. Scott, Alexandrea C. Jager, Meredith S. Gwin, Sarah B. Voth, Ron Balczon, Troy Stevens, Mike T. Lin · 2020 · Scientific Reports
61. Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
    Laura Gatti, Francesca Tinelli, Emma Scelzo, Francesco Arioli, Giuseppe Di Fede, Laura Piera Obici, Leonardo Pantoni, Giorgio Giaccone, Paola Caroppo, Eugenio Agostino Parati et al. · 2020 · International Journal of Molecular Sciences
62. Tau, prions and Aβ: the triad of neurodegeneration
    Lilla Reiniger, Ana Lukić, Jacqueline M. Linehan, Peter Rudge, John Collinge, Simon Mead, Sebastian Brandner · 2010 · Acta Neuropathologica
63. Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
    Janelle N. Fawver, Yonatan Ghiwot, Catherine Koola, Wesley Carrera, Jennifer Rodriguez-Rivera, Caterina M. Hernandez, Kelly T. Dineley, Yu Kong, Jianrong Li, Jack H. Jhamandas et al. · 2014 · Current Alzheimer Research
64. Neuropathology of iatrogenic Creutzfeldt–Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology
    Charles J. Duyckaerts, Véronique Sazdovitch, Kunié Ando, Danielle Seilhean, Nicolas Privat, Zehra Yilmaz, Laurène Peckeu, Élodie Bouaziz-Amar, Emmanuel E. Comoy, Aleksandra Maleska Maceski et al. · 2017 · Acta Neuropathologica
65. Frontal Cortex Neuropathology in Dementia Pugilistica
    Tommy Saing, Malcolm B. Dick, Peter T. Nelson, Ronald C. Kim, David H. Cribbs, Elizabeth Head · 2011 · Journal of Neurotrauma
66. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis
    Elaheh Ekhtiari Bidhendi, Johan Bergh, Per Zetterström, Karin Forsberg, Bente Pakkenberg, Peter Munch Andersen, Stefan L. Marklund, Thomas Brännström · 2018 · Acta Neuropathologica
67. Prion Protein Misfolding
    Leila Kupfer, Winfried Hinrichs, Martin H. Groschup · 2009 · Current Molecular Medicine
68. The route to protein aggregate superstructures: Particulates and amyloid‐like spherulites
    Valeria Vetri, Vito Foderà · 2015 · FEBS Letters
69. The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease
    Lary C. Walker, Juliane Schelle, Mathias Jucker · 2016 · Cold Spring Harbor Perspectives in Medicine
70. Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
    Uhlmann, Ruth E., Rother, Christine, Rasmussen, Jay, Schelle, Juliane, Bergmann, Carina, Ullrich Gavilanes, Emily M., Fritschi, Sarah K., Buehler, Anika, Baumann, Frank, Skodras, Angelos et al. · 2020 · Nature Neuroscience
71. Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures
    Hellwig, Sabine, Masuch, Annette, Nestel, Sigrun, Katzmarski, Natalie, Meyer-Luehmann, Melanie, Biber, Knut · 2015 · Scientific Reports
72. De novo generation of prion strains
    David W. Colby, Stanley B. Prusiner · 2011 · Nature Reviews Microbiology
73. Prions, prionoids and pathogenic proteins in Alzheimer disease
    Karen H. Ashe, Adriano Aguzzi · 2013 · Prion
74. Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease
    Carlo Condello, Jan Stöhr · 2017 · Neurobiology of Disease
75. Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism
    Abhisek Mukherjee, Diego Morales‐Scheihing, Natalia Salvadores, Inés Moreno‐González, César González, Kathleen Taylor-Presse, Nicolás Méndez, Mohammad Shahnawaz, Ahmed Osama Gaber, Omaima M. Sabek et al. · 2017 · The Journal of Experimental Medicine
76. Molecular subtypes of Alzheimer’s disease
    Giuseppe Di Fede, Marcella Catania, Emanuela Maderna, Roberta Ghidoni, Luisa Benussi, Elisa Tonoli, Giorgio Giaccone, Fabio Moda, Anna Paterlini, Ilaria Campagnani et al. · 2018 · Scientific Reports
77. Aβ oligomers trigger and accelerate Aβ seeding
    Natalie Katzmarski, Stephanie Ziegler‐Waldkirch, Nina Scheffler, Christian C. Witt, Claudia Abou‐Ajram, Brigitte Nuscher, Marco Prinz, Christian Haass, Melanie Meyer‐Luehmann · 2019 · Brain Pathology
78. Isomerization of the Asp7 Residue Results in Zinc‐Induced Oligomerization of Alzheimer’s Disease Amyloid β(1–16) Peptide
    Philipp O. Tsvetkov, Igor A. Popov, Е. Н. Николаев, Alexander I. Archakov, Alexander А. Makarov, Sergey A. Kozin · 2008 · ChemBioChem
79. The Three-Dimensional Structures of Amyloids
    Roland Riek · 2016 · Cold Spring Harbor Perspectives in Biology
80. Natural Compounds May Open New Routes to Treatment of Amyloid Diseases
    Jan Bieschke · 2013 · Neurotherapeutics
81. β-amyloid oligomers and cellular prion protein in Alzheimer’s disease
    Erik C. Gunther, Stephen M. Strittmatter · 2009 · Journal of Molecular Medicine
82. Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP
    Simon Mead, James B. Uphill, John Beck, Mark Poulter, Tracy Campbell, Jessica Lowe, Gary Adamson, Holger Hummerich, Norman Klopp, Ina‐Maria Rückert et al. · 2011 · Human Molecular Genetics
83. β-Amyloid Prions and the Pathobiology of Alzheimer’s Disease
    Joel C. Watts, Stanley B. Prusiner · 2017 · Cold Spring Harbor Perspectives in Medicine
84. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
    Christian Hansen, Jiayi Li · 2012 · Trends in Molecular Medicine
85. Prion-like aggregates: infectious agents in human disease
    Gunilla Torstensdotter Westermark, Per Westermark · 2010 · Trends in Molecular Medicine
86. A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
    Ebrima Gibbs, Judith M. Silverman, Beibei Zhao, Xubiao Peng, Jing Wang, Cheryl Lea Wellington, Ian R. Mackenzie, Steven Samuel Plotkin, Johanne M Kaplan, Neil R. Cashman · 2019 · Scientific Reports
87. Defined α-synuclein prion-like molecular assemblies spreading in cell culture
    Suzana Aulić, Tran Thanh Nhat Le, Fabio Moda, Saïda Abounit, Stefania Corvaglia, Loredana Casalis, Stefano Gustincich, Chiara Zurzolo, Fabrizio Tagliavini, Giuseppe Legname · 2014 · BMC Neuroscience
88. Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer’s Disease
    Tingting Zheng, Jiali Pu, Yanxing Chen, Yanfang Mao, Zhangyu Guo, Hongyu Pan, Ling Zhang, Heng Zhang, Binggui Sun, Baorong Zhang · 2017 · Frontiers in Aging Neuroscience
89. Tau prion-like propagation: state of the art and current challenges
    Dujardin, Simon, Hyman, Bradley T. · 2019 · Advances in Experimental Medicine and Biology
90. Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2
    Yi Zhang, Ben Zhi Zhou, Bo Deng, Fang Zhang, Jingxia Wu, Yuangao Wang, Yingying Le, Qiwei Zhai · 2012 · Diabetes
91. Murine models of Alzheimer's disease and their use in developing immunotherapies
    Thomas Wısnıewskı, Einar M. Sigurdsson · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
92. Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer’s disease
    Saiz-Sanchez, Daniel, De la Rosa-Prieto, Carlos, Ubeda-Banon, Isabel, Martinez-Marcos, Alino · 2015 · Brain Structure and Function
93. β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice
    Yini Zhao, Qiuyang Zheng, Yujuan Hong, Yue Gao, Jiaojiao Hu, Maoju Lang, Hongfeng Zhang, Ying Zhou, Hong Luo, Xian Zhang et al. · 2023 · Nature Neuroscience
94. Spontaneous generation of anchorless prions in transgenic mice
    Jan Stöhr, Joel C. Watts, Giuseppe Legname, Abby Oehler, Azucena Lemus, Hoang-Oanh B. Nguyen, Joshua Sussman, Holger Wille, Stephen J. DeArmond, Stanley B. Prusiner et al. · 2011 · Proceedings of the National Academy of Sciences
95. The value of incomplete mouse models of Alzheimer’s disease
    Rebecca Radde, Carmen Cecilia Duma, Michel Goedert, Mathias Jucker · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
96. Protein Quality Control in Health and Disease
    Tatyana Dubnikov, Tziona Ben‐Gedalya, Ehud Cohen · 2016 · Cold Spring Harbor Perspectives in Biology
97. Cellular mechanisms of protein aggregate propagation
    Brandon B. Holmes, Marc I. Diamond · 2012 · Current Opinion in Neurology
98. Copper(II) Coordination to Amyloid β: Murine versus Human Peptide
    Hélène Eury, Christian Bijani, Peter Faller, Christelle Hureau · 2010 · Angewandte Chemie International Edition
99. Fatal Aβ cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years
    Dominique Hervé, Maximilien Porché, Lucie Cabrejo, Céline Guidoux, Elisabeth Tournier‐Lasserve, Gaël Nicolas, Homa Adle‐Biassette, Isabelle Plu, Hugues Chabriat, Charles J. Duyckaerts · 2018 · Acta Neuropathologica
100. From molecule to molecule and cell to cell: Prion-like mechanisms in amyotrophic lateral sclerosis
     Leslie I. Grad, Sarah M. Fernando, Neil R. Cashman · 2015 · Neurobiology of Disease